51. Scleroderma Clinical trials / Disease details
Clinical trials : 523 / Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04986605 (ClinicalTrials.gov) | March 2022 | 1/6/2021 | Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis | The Effectiveness of ECP in Diffuse Cutaneous Systemic Sclerosis | Diffuse Cutaneous Systemic Sclerosis | Other: Extracorporeal Photopheresis (ECP) with Methoxsalen | Lawson Health Research Institute | Mallinckrodt | Not yet recruiting | 18 Years | N/A | All | 15 | Phase 2 | Canada |